The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Drug polymorphism and dosage form design: a practical perspective
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Characteristics and Significance of the Amorphous State in Pharmaceutical Systems
Hancock, B. C., & Zografi, G. (1997) · Journal of Pharmaceutical Sciences · doi:10.1021/js9601896 · Cited by 1,922
Amorphous pharmaceutical solids: preparation, characterization and stabilization
Yu, L. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00098-9 · Cited by 1,405
Solid state chemistry of drugs
Byrn, S. R. (1982) · Medical Entomology and Zoology · Cited by 1,086
Ritonavir: An Extraordinary Example of Conformational Polymorphism
Bauer, J., Spanton, S., Henry, R., Quick, J., Dziki, W., Porter, W., & Morris, J. (2001) · Pharmaceutical Research · doi:10.1023/a:1011052932607 · Cited by 1,071
Taylor, L. S., & Zografi, G. (1997) · Pharmaceutical Research · doi:10.1023/a:1012167410376 · Cited by 903
Pharmaceutical Applications of Polymorphism
Haleblian, J., & McCrone, W. (1969) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600580802 · Cited by 855
Pharmaceutical Solids: A Strategic Approach to Regulatory Considerations
Byrn, S. R., Pfeiffer, R. R., Ganey, M. E., Hoiberg, C. P., & Poochikian, G. (1995) · Pharmaceutical Research · doi:10.1023/a:1016241927429 · Cited by 476
Yoshioka, M., Hancock, B. C., & Zografi, G. (1994) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600831211 · Cited by 470
Craig, D. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(98)00338-x · Cited by 459
Morris, K. R., Griesser, U. J., Eckhardt, C. J., & Stowell, J. G. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00100-4 · Cited by 345
Effect of polymorphism on the absorption of chloramphenicol from chloramphenicol palmitate
Aguiar, A. J., Krc, J., Kinkel, A. W., & Samyn, J. C. (1967) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600560712 · Cited by 307
The Prediction, Morphology, and Mechanical Properties of the Polymorphs of Paracetamol
Beyer, T., Day, G. M., & Price, S. L. (2001) · Journal of the American Chemical Society · doi:10.1021/ja0102787 · Cited by 302
Oxidative degradation of pharmaceuticals: Theory, mechanisms and inhibition
Hovorka, S. W., & Schöneich, C. (2001) · Journal of Pharmaceutical Sciences · doi:10.1002/1520-6017(200103)90:3<253::aid-jps1>3.0.co;2-w · Cited by 297
Characterization of the solid-state: spectroscopic techniques
Bugay, D. E. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00101-6 · Cited by 296
Chemical reactivity in solid-state pharmaceuticals: formulation implications
Byrn, S. R., Xu, W., & Newman, A. W. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00102-8 · Cited by 259
Oh, D.-M., Curl, R. L., & Amidon, G. L. (1993) · Pharmaceutical Research · doi:10.1023/a:1018947113238 · Cited by 253
Stabilization of Pharmaceuticals to Oxidative Degradation
Waterman, K. C., Adami, R. C., Alsante, K. M., Hong, J., Landis, M. S., Lombardo, F., & Roberts, C. J. (2002) · Pharmaceutical Development and Technology · doi:10.1081/pdt-120002237 · Cited by 224
Predicting Fraction Dose Absorbed in Humans Using a Macroscopic Mass Balance Approach
Sinko, P. J., Leesman, G. D., & Amidon, G. L. (1991) · Pharmaceutical Research · doi:10.1023/a:1015892621261 · Cited by 178
Dissolution Behavior of Polymorphs of Chloramphenicol Palmitate and Mefenamic Acid
Aguiar, A. J., & Zelmer, J. E. (1969) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600580817 · Cited by 170
Hydrolysis in Pharmaceutical Formulations
Waterman, K. C., Adami, R. C., Alsante, K. M., Antipas, A. S., Arenson, D. R., Carrier, R., Hong, J., Landis, M. S., Lombardo, F., Shah, J. C., et al. (2002) · Pharmaceutical Development and Technology · doi:10.1081/pdt-120003494 · Cited by 161
The Bioinequivalence of Carbamazepine Tablets with a History of Clinical Failures
Meyer, M. C., Straughn, A. B., Jarvi, E. J., Wood, G. C., Pelsor, F. R., & Shah, V. P. (1992) · Pharmaceutical Research · doi:10.1023/a:1015872626887 · Cited by 157
Scientific Considerations of Pharmaceutical Solid Polymorphism in Abbreviated New Drug Applications
Yu, L. X., Furness, M. S., Raw, A., Outlaw, K. P. W., Nashed, N. E., Ramos, E., Miller, S. P. F., Adams, R. C., Fang, F., Patel, R. M., et al. (2003) · Pharmaceutical Research · doi:10.1023/a:1023285627778 · Cited by 126
Comparison of the mechanical properties of the crystalline and amorphous forms of a drug substance
Hancock, B. C., Carlson, G. T., Ladipo, D. D., et al. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00133-3 · Cited by 110
Lai, M. C., Hageman, M. J., Schowen, R. L., Borchardt, R. T., & Topp, E. M. (1999) · Journal of Pharmaceutical Sciences · doi:10.1021/js980227g · Cited by 70
Lai, M. C., Hageman, M. J., Schowen, R. L., Borchardt, R. T., Laird, B. B., & Topp, E. M. (1999) · Journal of Pharmaceutical Sciences · doi:10.1021/js9802289 · Cited by 59
Chemical Kinetics and Drug Stability
Attwood, D., & Poust, R. I. (2009) · CRC Press eBooks · doi:10.3109/9781420065657-10 · Cited by 26
Use of rabbits for absorption studies on polymorphs of chloramphenicol palmitate.
MAEDA, T., Takenaka, H., Yamahira, Y., & NOGUCHI, T. (1980) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.28.431 · Cited by 16
Macek, T. J. (1966) · PubMed · Cited by 7
Cited by
Biological Activity of Ionic Liquids and Their Application in Pharmaceutics and Medicine
Egorova, K. S., Gordeev, E. G., & Ananikov, V. P. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00562 · Cited by 1,649
Strategies to Address Low Drug Solubility in Discovery and Development
Williams, H. D., Trevaskis, N. L., Charman, S. A., Shanker, R. M., Charman, W. N., Pouton, C. W., & Porter, C. J. H. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.005660 · Cited by 1,570
Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates
Blagden, N., de Matas, M., Gavan, P. T., & York, P. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.05.011 · Cited by 1,448
Terahertz technology and its applications
Pawar, A. Y., Sonawane, D. D., Erande, K. B., & Derle, D. V. (2013) · Drug Invention Today · doi:10.1016/j.dit.2013.03.009 · Cited by 551
Polymorph Impact on the Bioavailability and Stability of Poorly Soluble Drugs
Censi, R., & Di Martino, P. (2015) · Molecules · doi:10.3390/molecules201018759 · Cited by 512
Metadata
- Authors
- Singhal, D.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2004-02-23
- Volume
- 56
- Issue
- 3
- Pages
- 335-347
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W2086999377
- Cited by
- 596
- References
- 28
- FWCI
- 4.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.